Genentech, Biogen Idec Gain Approval Of Rituxan In RA March 2, 2006 By Aaron Lorenzo The FDA approved Rituxan (rituximab) for rheumatoid arthritis, broadening the therapeutic antibody’s label and potentially its revenue. (BioWorld Today)Read More
